BUY Info Edge (India) Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))28 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·27 Jul · yesterday
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·27 Jul · yesterday
Yes Madam Hits 30,000 June Bookings Amid Home Beauty Race
NewsGoogle News·15 Jul · 2w ago
Info Edge fixes record date for ₹3.60 dividend, AGM on Aug 25
NewsGoogle News·22 Jul · 5d ago
Ashish Gupta ceases as Info Edge Independent Director
NewsGoogle News·20 Jul · 1w ago
Info Edge Limited Announces Cessation of Ashish Gupta from Director Role, Effective July 20, 2026
NewsGoogle News·20 Jul · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Info Edge (India)
- BUY — Akshay Bhagwat, JM Financial19 Oct 2026 · ~2 weeks · target ₹1,300 · Active
- BUY — Prakash Gaba19 Oct 2026 · Same day · target ₹1,280 · SL hit
- BUY — Ansh Jogendra Bhilwar19 Oct 2026 · ~2 weeks · target ₹1,312 · SL hit
- BUY — Rakesh Bansal16 Oct 2026 · ~2 weeks · target ₹1,385 · Active
- BUY — Osho Krishan, Angel One16 Oct 2026 · ~2 weeks · target ₹1,290 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

